查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417541

C 反应蛋白 (CRP) 测试市场报告：2030 年趋势、预测和竞争分析

C-Reactive Protein Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

C反应蛋白检测的趋势与预测

到 2030 年，全球 C 反应蛋白检测市场预计将达到 61 亿美元，2024 年至 2030 年复合年增长率为 2.8%。该市场的主要驱动力是心血管疾病发病率的上升、旨在引入照护现场筛检和开发 C 反应蛋白 (CRP) 检测尖端方法的政府计划的扩大；以及慢性病发病率的增加例如心血管疾病、类风湿性关节炎和发炎疾病。全球 C 反应蛋白检测市场的未来前景广阔，诊所、医院、实验室、辅助生活医疗机构、家庭市场等领域都有机会。

C-反应蛋白测试市场洞察

Lucintel 预测，由于心血管疾病的发生率不断增加，心血管疾病在预测期内仍将是最大的细分市场。

由于心血管疾病盛行率上升、产品推出频繁以及现有行业竞争对手的存在，北美在预测期内将继续成为最大的地区。

常问问题

Q1.市场规模有多大？

A1. 到 2030 年，全球 C 反应蛋白检测市场预计将达到 61 亿美元。

Q2.市场成长预测如何？

A2. 2024年至2030年，全球C反应蛋白检测市场预计将以2.8%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些？

A3. 该市场的主要驱动力是心血管疾病发病率的上升、旨在引入照护现场和开发 C 反应蛋白 (CRP) 检测尖端方法的政府计划的扩大；以及慢性病患病率的增加例如心血管疾病、类风湿性关节炎和发炎疾病。

Q4.市场的主要细分市场是什么？

A4. 全球 C 反应蛋白检测市场的未来对于诊所、医院、实验室、辅助生活医疗机构和家庭市场来说都是充满希望的。

Q5. 市场上主要企业有哪些？

A5.主要C反应蛋白检测公司如下。

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计，由于心血管疾病的发生率不断增加，心血管疾病在预测期内仍将是其最大的细分市场。

Q7. 未来五年预计哪个地区将成为最大的市场？

A7. 由于心血管疾病盛行率上升、产品推出频繁以及现有产业竞争对手的存在，北美在预测期内将继续成为最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章 全球C反应蛋白检测市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球C反应蛋白检测市场趋势（2018-2023）与预测（2024-2030）
  • 按检测法分類的全球 C 反应蛋白检测市场
    • 检测法
    • 酵素连结免疫吸附法
    • 化学冷光免疫检测
    • 其他的
  • 按检测范围分類的全球 C 反应蛋白检测市场
    • hsCRP（高敏感性CRP）
    • 常规CRP
    • cCRP（CardioPhase）
  • 按疾病分類的全球 C 反应蛋白检测市场
    • 心血管疾病
    • 癌症
    • 类风湿性关节炎
    • 发炎性肠道疾病
    • 子宫内膜异位症
    • 狼疮
    • 其他的
  • 按最终用途分類的全球 C 反应蛋白测试市场
    • 诊所
    • 医院
    • 实验室
    • 生活支援医疗设施
    • 在家里
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球 C 反应蛋白检测市场
  • 北美C反应蛋白检测市场
  • 欧洲C反应蛋白检测市场
  • 亚太C反应蛋白检测市场
  • 其他地区C反应蛋白检测市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按检测类型分類的全球 C 反应蛋白检测市场成长机会
    • 按检测范围分類的全球 C 反应蛋白检测市场成长机会
    • 全球 C 反应蛋白检测市场按疾病分類的成长机会
    • 按最终用途分類的全球 C 反应蛋白测试市场的成长机会
    • 全球 C 反应蛋白测试市场成长机会（按地区）
  • 全球C反应蛋白检测市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球 C 反应蛋白检测市场的产能扩张
    • 全球C反应蛋白检测市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech
简介目录

C-Reactive Protein Testing Trends and Forecast

The future of the global C-reactive protein testing market looks promising with opportunities in the clinic, hospital, laboratories, assisted living healthcare facilities, and home markets. The global C-reactive protein testing market is expected to reach an estimated $6.1 billion by 2030 with a CAGR of 2.8% from 2024 to 2030. The major drivers for this market are rising frequency of cardiovascular disorders, expanding government programs to introduce point-of-care screening and create cutting-edge methods for C-reactive protein (CRP) testing, as well as, increasing rates of chronic illnesses such cardiovascular disease, rheumatoid arthritis, and inflammatory disorders.

A more than 150-page report is developed to help in your business decisions.

C-Reactive Protein Testing by Segment

The study includes a forecast for the global C-reactive protein testing by assay type, detection range, disease, end use, and region.

C-Reactive Protein Testing Market by Assay Type [Shipment Analysis by Value from 2018 to 2030]:

  • Immunoturbidimetric Assay
  • ELISA
  • Chemiluminescence Immunoassay
  • Others

C-Reactive Protein Testing Market by Detection Range [Shipment Analysis by Value from 2018 to 2030]:

  • hs-CRP
  • Conventional CRP
  • cCRP

C-Reactive Protein Testing Market by Disease [Shipment Analysis by Value from 2018 to 2030]:

  • Cardiovascular Diseases
  • Cancer
  • Rheumatoid Arthritis
  • Inflammatory Bowel Disease
  • Endometriosis
  • Lupus
  • Others

C-Reactive Protein Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Clinics
  • Hospitals
  • Laboratories
  • Assisted Living Healthcare Facilities
  • Home
  • Others

C-Reactive Protein Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of C-Reactive Protein Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies C-reactive protein testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the C-reactive protein testing companies profiled in this report include-

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

C-Reactive Protein Testing Market Insights

Lucintel forecasts that cardiovascular diseases will remain the largest segment over the forecast period due to the rise in the frequency of cardiovascular disorders.

North America will remain the largest region over the forecast period due to rising cardiovascular disease incidence, a regular stream of product introductions, and the existence of established industry competitors.

Features of the Global C-Reactive Protein Testing Market

Market Size Estimates: C-reactive protein testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: C-reactive protein testing market size by various segments, such as by assay type, detection range, disease, end use, and region in terms of value ($B).

Regional Analysis: C-reactive protein testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different assay type, detection range, disease, end use, and regions for the C-reactive protein testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the C-reactive protein testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the C-reactive protein testing market size?

Answer: The global C-reactive protein testing market is expected to reach an estimated $6.1 billion by 2030.

Q2. What is the growth forecast for C-reactive protein testing market?

Answer: The global C-reactive protein testing market is expected to grow with a CAGR of 2.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the C-reactive protein testing market?

Answer: The major drivers for this market are rising frequency of cardiovascular disorders, expanding government programs to introduce point-of-care screening and create cutting-edge methods for C-reactive protein (CRP) testing, as well as, increasing rates of chronic illnesses such cardiovascular disease, rheumatoid arthritis, and inflammatory disorders.

Q4. What are the major segments for C-reactive protein testing market?

Answer: The future of the global C-reactive protein testing market looks promising with opportunities in the clinic, hospital, laboratories, assisted living healthcare facilities, and home markets.

Q5. Who are the key C-reactive protein testing market companies?

Answer: Some of the key C-reactive protein testing companies are as follows.

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

Q6. Which C-reactive protein testing market segment will be the largest in future?

Answer: Lucintel forecasts that cardiovascular diseases will remain the largest segment over the forecast period due to the rise in the frequency of cardiovascular disorders.

Q7. In C-reactive protein testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising cardiovascular disease incidence, a regular stream of product introductions, and the existence of established industry competitors.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the C-reactive protein testing market by assay type (immunoturbidimetric assay, elisa, chemiluminescence immunoassay, and others), detection range (hs-CRP, conventional CRP, and cCRP), disease (cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus, and others), end use (clinics, hospitals, laboratories, assisted living healthcare facilities, home, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global C-Reactive Protein Testing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global C-Reactive Protein Testing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global C-Reactive Protein Testing Market by Assay Type
    • 3.3.1: Immunoturbidimetric Assay
    • 3.3.2: ELISA
    • 3.3.3: Chemiluminescence Immunoassay
    • 3.3.4: Others
  • 3.4: Global C-Reactive Protein Testing Market by Detection Range
    • 3.4.1: hs-CRP
    • 3.4.2: Conventional CRP
    • 3.4.3: cCRP
  • 3.5: Global C-Reactive Protein Testing Market by Disease
    • 3.5.1: Cardiovascular Diseases
    • 3.5.2: Cancer
    • 3.5.3: Rheumatoid Arthritis
    • 3.5.4: Inflammatory Bowel Disease
    • 3.5.5: Endometriosis
    • 3.5.6: Lupus
    • 3.5.7: Others
  • 3.6: Global C-Reactive Protein Testing Market by End Use
    • 3.6.1: Clinics
    • 3.6.2: Hospitals
    • 3.6.3: Laboratories
    • 3.6.4: Assisted Living Healthcare Facilities
    • 3.6.5: Home
    • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global C-Reactive Protein Testing Market by Region
  • 4.2: North American C-Reactive Protein Testing Market
    • 4.2.1: North American C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
    • 4.2.2: North American C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
  • 4.3: European C-Reactive Protein Testing Market
    • 4.3.1: European C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
    • 4.3.2: European C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
  • 4.4: APAC C-Reactive Protein Testing Market
    • 4.4.1: APAC C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
    • 4.4.2: APAC C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
  • 4.5: ROW C-Reactive Protein Testing Market
    • 4.5.1: ROW C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
    • 4.5.2: ROW C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global C-Reactive Protein Testing Market by Assay Type
    • 6.1.2: Growth Opportunities for the Global C-Reactive Protein Testing Market by Detection Range
    • 6.1.3: Growth Opportunities for the Global C-Reactive Protein Testing Market by Disease
    • 6.1.4: Growth Opportunities for the Global C-Reactive Protein Testing Market by End Use
    • 6.1.5: Growth Opportunities for the Global C-Reactive Protein Testing Market by Region
  • 6.2: Emerging Trends in the Global C-Reactive Protein Testing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global C-Reactive Protein Testing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global C-Reactive Protein Testing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Danaher
  • 7.4: Quest Diagnostics
  • 7.5: Siemens Healthineers
  • 7.6: Abbott
  • 7.7: Merck
  • 7.8: Zoetis
  • 7.9: Ortho Clinical Diagnostics
  • 7.10: Getein Biotech